What to Expect From Walmart's (WMT) Q2 Earnings

Walmart WMT has seen its stock price climb over 4% in the last month. Shares of WMT also popped on Friday, just less than a week before the retail behemoth reports its quarterly financial results. So let's do a quick preview of what investors should expect from Walmart's second-quarter earnings.

Shares of Walmart are up just around 12% over the last year, which lags the S&P 500's nearly 18% climb as the company tries to find its footing in the new retail age. The company has adapted to the e-commerce revolution, along with the likes of Target TGT , Costco COST , and others, in order to fight off Amazon's AMZN growing sway over consumers.

Last quarter, Walmart's revenues climbed 4.4% from the year-ago period to hit $122.7 billion. Meanwhile, the company's adjusted earnings surged by 14% to reach $1.14 per share, which also topped the Zacks Consensus Estimate of $1.12 per share.

Investors might be a bit less pleased to remember that Walmart's U.S. comp sales only climbed by 2.1%. But the firm's e-commerce sales soared 33%.

Plus, Walmart announced in March its plan to expand its online grocery delivery offerings to more than 100 metro areas by the end of the year, up from just six. Meanwhile, the big-box giant also offers an order online, curbside pickup service called "Grocery Hero" at 1,200 stores, with Walmart expected to add it at 1,000 more locations by the end of 2018.

Second Quarter

Walmart's Q2 revenues are projected to pop by roughly 1.9% to hit $125.66 billion, based on our current Zacks Consensus Estimate. For the full-year, WMT's revenues are projected to climb by 2.5% to reach $512.69 billion.

At the other end of the income statement, the retailer is projected to see its adjusted second-quarter earnings climb by just over 12% to touch $1.21 per share. Looking even further ahead, Walmart's fiscal year earnings are projected to jump by 8.82% to $4.81 per share.

However, investors should note that Walmart's earnings revision activity has trended in the wrong direction recently for both Q2 and its current fiscal year.

Walmart is set to release its quarterly financial results before the market opens on Thursday, August 16.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report, Inc. (AMZN): Free Stock Analysis Report

Walmart Inc. (WMT): Free Stock Analysis Report

Target Corporation (TGT): Free Stock Analysis Report

Costco Wholesale Corporation (COST): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More